Digital PCR Market to Exhibit 17.2% CAGR and Reach USD 799.1 Million by 2026; Rise Remarkably on Account of Increasing Prevalence of Genetic Disorder Cases, reports Fortune Business Insights™

NEXT STORY
Teleflex to Present at the Stephens Investment Conference 2020
PREV STORY
Tiziana Announces Initiation of Clinical Trial with Covid-19 Patients in Brazil with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Results of the annual shareholders’ meeting held on 11 May 2018

PRESS RELEASE: REGULATED INFORMATION11 May 2018, 17:40 CEST                                                            Results of the annual shareholders' ...

author_avatar
NASDAQ Market News

Novartis’ new analyses reinforce the potential of Ultibro® Breezhaler® for COPD patients historically treated with steroids

New analyses from the FLAME study suggest dual bronchodilator Ultibro® Breezhaler® provides similar or ...

author_avatar
NASDAQ Market News

Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018

NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

author_avatar
NASDAQ Market News